Mapfre

COVID-19 fragility

26/03/20 -"The reduction in our target price was driven by lower earnings for 2020-22 and the increase in the discount, attributed to P/Book, P/E and dividend yield relative to its peers, from 20% to 40%. This ..."

PDF page sample
Pages
50
Language
English
Published on
26/03/20
Download
You may also be interested by these reports :
11/09/25
Generali (ADD; Italy) plays a pivotal role in the Italian financial system and sits at the centre of manoeuvres that have shaken the country’s ...
10/09/25
Despite a muted topline, Baloise reported a sharp increase in profit in 1H25, driven by the non-life business. Looking ahead, the company confirmed a ...
09/09/25
Like every September, executives from across the insurance and reinsurance industry are gathering in Monte Carlo to discuss industry trends, pricing ...
01/09/25
We have incorporated the 1H25 results into our model and revised our forecasts accordingly. In 1H25, operating profit was slightly ahead of ...

EXECUTIVE SUMMARY

Updates Pension Risks
Target & Opinion Governance & Management
Business & Trends Graphics : Momentum
Money Making Graphics : MACD & Volumes
Debt Graphics : Sensitivities
Valuation Sector: Performance
DCF Sector: Key data
NAV/SOTP Sector: Ratios & Valorisation
Worth knowing Sector: Peers
Financials Sector: Analysis

CONFLICTS OF INTEREST

AlphaValue does not have nor seek any business with companies covered in AlphaValue Research paid by subscription. As a result, investors can be confident that there is no conflict of interest that could affect the objectivity of AlphaValue Research.

Corporate broking NO
Trading in corporate shares NO
Analyst ownership NO
Advising of corporate (strategy, marketing, debt, etc) NO
Research paid for by corporate NO
Provision of corporate access paid for by corporate NO
Link between and a banking entity NO
Brokerage activity at AlphaValue NO